OpenLegislation

Paragraph 35 Traditional herbal registrations

(1)

Subject to sub-paragraphs (3) to (6), the fee payable under regulation 12(1)(a) in connection with an application for a traditional herbal registration of a kind described in column 1 of the following table is the fee specified in the corresponding entry in column 2 of that table.

Fee for application for traditional herbal registration

Column 1Column 2
Kind of applicationFee payable
1. Complex registration application
(a)in respect of a medicinal product containing a single active ingredientF1£5,899
(b)in any other caseF2£8,848
2. Standard registration application
(a)in respect of a medicinal product containing 3 or fewer active ingredientsF3£2,950
(b)in any other caseF4£4,424
3. Reduced registration application category II
(a)in respect of a medicinal product containing 3 or fewer active ingredientsF5£983
(b)in any other caseF6£1,476
4. Reduced registration application category I
(a)in respect of a medicinal product containing 3 or fewer active ingredientsF7£657
(b)in any other caseF8£983
5. Change of ownership applicationF9£592
(2)

Each reference in sub-paragraphs (3) to (6) to an amount payable under sub-paragraph (1) in respect of an application refers to the amount payable under that sub-paragraph in respect of an application of the kind in question.

(3)

Where an application relates to a medicinal product which contains one or more vitamins or minerals which are vitamins or minerals from a new source, a fee of—

(a)

F10£1,311, if European Pharmacopoeia certificates of suitability covering all the vitamins or minerals which are a vitamin or mineral from a new source have been submitted with the application; or

(b)

F11£2,622, in any other case,

is payable in addition to the amount payable under sub-paragraph (1) in respect of that application.

(4)

Where an application relates to a medicinal product which contains one or more new excipients, an amount of F12£8,748 is payable in addition to the amount payable under sub-paragraph (1) in respect of that application.

(5)

Where an application relates to a medicinal product which contains one or more TSE risk excipients from a new source, an amount of F13£777 is payable in addition to the amount payable under sub-paragraph (1) in respect of that application.

(6)

Where an application relates to a medicinal product which is a sterile medicinal product, an amount of F14£2,622 is payable in addition to the amount payable under sub-paragraph (1) in respect of that application.

Annotations

Textual amendments

F1

Sum in Sch. 2 para. 35(1) Table Entry 1(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(i)(aa)

F2

Sum in Sch. 2 para. 35(1) Table Entry 1(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(i)(bb)

F3

Sum in Sch. 2 para. 35(1) Table Entry 2(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(ii)(aa)

F4

Sum in Sch. 2 para. 35(1) Table Entry 2(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(ii)(bb)

F5

Sum in Sch. 2 para. 35(1) Table Entry 3(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(iii)(aa)

F6

Sum in Sch. 2 para. 35(1) Table Entry 3(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(iii)(bb)

F7

Sum in Sch. 2 para. 35(1) Table Entry 4(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(iv)(aa)

F8

Sum in Sch. 2 para. 35(1) Table Entry 4(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(iv)(bb)

F9

Sum in Sch. 2 para. 35(1) Table Entry 5 substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(a)(v)

F10

Sum in Sch. 2 para. 35(3)(a) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(b)(i)

F11

Sum in Sch. 2 para. 35(3)(b) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(b)(ii)

F12

Sum in Sch. 2 para. 35(4) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(c)

F13

Sum in Sch. 2 para. 35(5) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(d)

F14

Sum in Sch. 2 para. 35(6) substituted (1.4.2025) by The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2025 (S.I. 2025/317), regs. 1(2), 27(12)(e)